Process View
Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte migration.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of leukocyte migration"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
HOXB5 | homeobox B5 | 0.993 | Human | |
HOXA10 | homeobox A10 | 0.612 | ||
PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.538 | Human | |
CCL19 | chemokine (C-C motif) ligand 19 | 0.518 | Human | |
HOXB6 | homeobox B6 | 0.500 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.499 | Human | |
TFF1 | trefoil factor 1 | 0.464 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.464 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.444 | Human | |
APOE | apolipoprotein E | 0.407 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.406 | Human | |
C19orf50 | chromosome 19 open reading frame 50 | 0.396 | ||
CFH | complement factor H | 0.340 | ||
HOXA4 | homeobox A4 | 0.320 | Human | |
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.282 | ||
HOXB9 | homeobox B9 | 0.254 | ||
HOXB3 | homeobox B3 | 0.246 | ||
HOXB7 | homeobox B7 | 0.245 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.222 | ||
TBXA2R | thromboxane A2 receptor | 0.203 | Human | |
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.201 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.181 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.176 | ||
HOXA6 | homeobox A6 | 0.151 | Human | |
IDE | insulin-degrading enzyme | 0.115 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.112 | Human | |
HOXC6 | homeobox C6 | 0.111 | Human | |
IL1B | interleukin 1, beta | 0.109 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.106 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.102 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.091 | Human | |
CCL3 | chemokine (C-C motif) ligand 3 | 0.076 | Human | |
HOXC10 | homeobox C10 | 0.073 | ||
HOXA11 | homeobox A11 | 0.069 | ||
HOXA2 | homeobox A2 | 0.064 | ||
HOXC4 | homeobox C4 | 0.063 | Human | |
HOXA5 | homeobox A5 | 0.063 | Human | |
DARC | Duffy blood group, chemokine receptor | 0.060 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.059 | ||
HOXA3 | homeobox A3 | 0.049 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.048 | ||
DPT | dermatopontin | 0.046 | ||
ADORA2A | adenosine A2a receptor | 0.045 | ||
FBLN1 | fibulin 1 | 0.044 | ||
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.042 | ||
RGS1 | regulator of G-protein signaling 1 | 0.041 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.040 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.038 | ||
HOXA7 | homeobox A7 | 0.038 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.038 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.037 | ||
ARRB1 | arrestin, beta 1 | 0.035 | ||
CFI | complement factor I | 0.033 | ||
TNF | tumor necrosis factor | 0.032 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.030 | ||
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.029 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.027 | ||
PRDX4 | peroxiredoxin 4 | 0.027 | ||
IL8 | interleukin 8 | 0.027 | ||
CH25H | cholesterol 25-hydroxylase | 0.026 | ||
GHRL | ghrelin/obestatin prepropeptide | 0.026 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.026 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.025 | Human | |
IL10 | interleukin 10 | 0.025 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.024 | ||
NKG7 | natural killer cell group 7 sequence | 0.023 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.023 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.023 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.023 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.022 | Human | |
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.022 | ||
HK3 | hexokinase 3 (white cell) | 0.021 | ||
VCAN | versican | 0.021 | ||
HOXA1 | homeobox A1 | 0.020 | ||
SELE | selectin E | 0.020 | ||
MSC | musculin | 0.020 | ||
C7 | complement component 7 | 0.020 | ||
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.020 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
HOXC5 | homeobox C5 | 0.019 | Human | |
C1S | complement component 1, s subcomponent | 0.019 | ||
HOXB4 | homeobox B4 | 0.019 | Human | |
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.018 | ||
CFB | complement factor B | 0.018 | ||
MYH11 | myosin, heavy chain 11, smooth muscle | 0.018 | ||
NNMT | nicotinamide N-methyltransferase | 0.018 | ||
HOXB2 | homeobox B2 | 0.018 | ||
HOXC9 | homeobox C9 | 0.018 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.017 | ||
IL10RA | interleukin 10 receptor, alpha | 0.017 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.017 | Human | |
HOXB8 | homeobox B8 | 0.017 | Human | |
ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.016 | ||
MGP | matrix Gla protein | 0.016 | ||
IL2RG | interleukin 2 receptor, gamma | 0.016 | ||
SRGN | serglycin | 0.016 | ||
HOXC11 | homeobox C11 | 0.015 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.015 | ||
IL21R | interleukin 21 receptor | 0.015 | ||
PDZD3 | PDZ domain containing 3 | 0.015 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.015 | ||
SEPT8 | septin 8 | 0.015 | ||
C5AR1 | complement component 5a receptor 1 | 0.014 | ||
KRT81 | keratin 81 | 0.014 | ||
COL14A1 | collagen, type XIV, alpha 1 | 0.014 | ||
SMAD6 | SMAD family member 6 | 0.014 | ||
HOXD8 | homeobox D8 | 0.013 | Human | |
IFNG | interferon, gamma | 0.013 | ||
HOXC8 | homeobox C8 | 0.013 | Human | |
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.013 | ||
DCN | decorin | 0.013 | ||
MXRA8 | matrix-remodelling associated 8 | 0.013 | ||
FPR3 | formyl peptide receptor 3 | 0.013 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.013 | ||
CD69 | CD69 molecule | 0.013 | ||
KRT15 | keratin 15 | 0.013 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.012 | ||
DRD2 | dopamine receptor D2 | 0.012 | ||
SOD3 | superoxide dismutase 3, extracellular | 0.012 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.012 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.012 | Human | |
IL2RB | interleukin 2 receptor, beta | 0.011 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.011 | ||
PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.011 | ||
SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.011 | ||
CD83 | CD83 molecule | 0.011 | ||
SPDEF | SAM pointed domain containing ets transcription factor | 0.011 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.011 | ||
GGT5 | gamma-glutamyltransferase 5 | 0.011 | ||
PDX1 | pancreatic and duodenal homeobox 1 | 0.011 | ||
HOXD10 | homeobox D10 | 0.011 | ||
IL2RA | interleukin 2 receptor, alpha | 0.011 | ||
GNLY | granulysin | 0.011 | ||
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.011 | ||
GNRH2 | gonadotropin-releasing hormone 2 | 0.011 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.010 | Human | |
SLAMF8 | SLAM family member 8 | 0.010 | ||
CCND1 | cyclin D1 | 0.010 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.010 | ||
COL13A1 | collagen, type XIII, alpha 1 | 0.010 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.010 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.010 | ||
SIGLEC8 | sialic acid binding Ig-like lectin 8 | 0.010 | ||
HOXD3 | homeobox D3 | 0.010 |